O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait
Clinical trial NCT05716724 · COMPLETED
Trial details
- NCT number
- NCT05716724
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-25
- Primary completion
- 2023-07-09
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.